Hoe 140, desarg(10)- | CAS#138680-92-9 | B1 bradykinin antagonist

MedKoo Cat#: 596741 | Name: Hoe 140, desarg(10)-

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Hoe 140, desarg(10)- is a potent B1 bradykinin antagonist.

Chemical Structure

Hoe 140, desarg(10)-

CAS#138680-92-9

Theoretical Analysis

MedKoo Cat#: 596741

Name: Hoe 140, desarg(10)-

CAS#: 138680-92-9

Chemical Formula: C53H77N15O12S

Exact Mass: 1147.5597

Molecular Weight: 1148.35

Elemental Analysis: C, 55.43; H, 6.76; N, 18.30; O, 16.72; S, 2.79

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Hoe 140, desarg(10)-; 10-Desarg-hoe 140;

IUPAC/Chemical Name

(2S,3aS,7aS)-4-(D-arginyl-L-arginyl-L-prolyl)-2-(((S)-2-amino-3-(thiophen-2-yl)propanoyl)-L-seryl)-3a-(((2S)-4-hydroxypyrrolidine-2-carbonyl)glycyl)-3-(5,6,7,8-tetrahydroisoquinoline-1-carbonyl)octahydro-1H-indole-2-carboxylic acid

InChi Key

NZVSWJBJOVGTMD-HBRAAJGISA-N

InChi Code

InChI=1S/C53H77N15O12S/c54-32(12-4-17-61-50(56)57)45(75)65-34(13-5-18-62-51(58)59)48(78)68-20-6-14-37(68)41(72)31-11-3-15-38-52(31,39(71)25-64-47(77)35-22-28(70)24-63-35)43(42(73)40-30-10-2-1-8-27(30)16-19-60-40)53(67-38,49(79)80)44(74)36(26-69)66-46(76)33(55)23-29-9-7-21-81-29/h7,9,16,19,21,28,31-38,43,63,67,69-70H,1-6,8,10-15,17-18,20,22-26,54-55H2,(H,64,77)(H,65,75)(H,66,76)(H,79,80)(H4,56,57,61)(H4,58,59,62)/t28?,31?,32-,33+,34+,35+,36+,37+,38+,43?,52+,53+/m1/s1

SMILES Code

O=C(N[C@H](C([C@]1(C(O)=O)C(C(c2nccc3c2CCCC3)=O)[C@]4(C(CNC([C@@H]5CC(O)CN5)=O)=O)[C@H](CCCC4C([C@@H]6CCCN6C([C@@H](NC([C@H](N)CCCNC(N)=N)=O)CCCNC(N)=N)=O)=O)N1)=O)CO)[C@@H](N)Cc7sccc7

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,148.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Bujalska-Zadrożny M, de Cordé A, Cegielska-Perun K, Gąsińska E, Makulska-Nowak H. Dose-depending effect of intracerebroventricularly administered bradykinin on nociception in rats. Pharmacol Rep. 2013;65(4):1006-11. PubMed PMID: 24145095. 2: Lim SK, Park SH. The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis. Life Sci. 2012 Nov 2;91(19-20):895-906. doi: 10.1016/j.lfs.2012.07.020. Epub 2012 Jul 31. PubMed PMID: 22877648. 3: Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, Maggi CA. Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol. 2011 Feb;162(3):611-22. doi: 10.1111/j.1476-5381.2010.01062.x. PubMed PMID: 20946124; PubMed Central PMCID: PMC3041251. 4: Meini S, Cucchi P, Catalani C, Bellucci F, Santicioli P, Giuliani S, Maggi CA. Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle. Eur J Pharmacol. 2010 Jun 10;635(1-3):34-9. doi: 10.1016/j.ejphar.2010.03.012. Epub 2010 Mar 20. PubMed PMID: 20307535. 5: Lim SK, Han HJ, Kim KY, Park SH. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. J Cell Physiol. 2009 Dec;221(3):677-87. doi: 10.1002/jcp.21906. PubMed PMID: 19725054. 6: Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, Newby DE. Vascular B1 kinin receptors in patients with congestive heart failure. J Cardiovasc Pharmacol. 2008 Nov;52(5):438-44. doi: 10.1097/FJC.0b013e31818c66cb. PubMed PMID: 19033823. 7: Bellucci F, Cucchi P, Santicioli P, Lazzeri M, Turini D, Meini S. Characterization of kinin receptors in human cultured detrusor smooth muscle cells. Br J Pharmacol. 2007 Jan;150(2):192-9. Epub 2006 Dec 18. PubMed PMID: 17179953; PubMed Central PMCID: PMC2042898. 8: Fabiyi AC, Brading AF. The use of the isolated mouse whole bladder for investigating bladder overactivity. J Pharmacol Exp Ther. 2006 Dec;319(3):1386-94. Epub 2006 Aug 30. PubMed PMID: 16943254. 9: Levant A, Levy E, Argaman M, Fleisher-Berkovich S. Kinins and neuroinflammation: dual effect on prostaglandin synthesis. Eur J Pharmacol. 2006 Sep 28;546(1-3):197-200. Epub 2006 Jul 5. PubMed PMID: 16889769. 10: Chan SK, Rudd JA. Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileum. Eur J Pharmacol. 2006 Jun 6;539(1-2):108-15. Epub 2006 Apr 6. PubMed PMID: 16650846. 11: Ongali B, Campos MM, Petcu M, Rodi D, Cloutier F, Chabot JG, Thibault G, Couture R. Expression of kinin B1 receptors in the spinal cord of streptozotocin-diabetic rat. Neuroreport. 2004 Nov 15;15(16):2463-6. PubMed PMID: 15538175. 12: Eric J, Gabra BH, Sirois P. Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice. Br J Pharmacol. 2003 Apr;138(8):1589-97. PubMed PMID: 12721115; PubMed Central PMCID: PMC1573809. 13: Huang CD, Tliba O, Panettieri RA Jr, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol. 2003 Mar;28(3):330-8. PubMed PMID: 12594059. 14: Sot U, Misterek K, Gumułka SW, Dorociak A. Intrathecal bradykinin administration: opposite effects on nociceptive transmission. Pharmacology. 2002 Oct;66(2):76-80. PubMed PMID: 12207114. 15: Cucchi P, Meini S, Quartara L, Giolitti A, Zappitelli S, Rotondaro L, Maggi CA. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor. Peptides. 2002 Aug;23(8):1457-63. PubMed PMID: 12182947. 16: Li Y, Sato T. Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J Mol Cell Cardiol. 2001 Nov;33(11):2047-53. PubMed PMID: 11708848. 17: Wille PR, Vitor R, Gabilan NH, Nicolau M. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues. Mediators Inflamm. 2001 Jun;10(3):163-7. PubMed PMID: 11545253; PubMed Central PMCID: PMC1781703. 18: Bentley KR, Jarrott B. Lipopolysaccharide decreases bradykinin receptor-induced acidification responses in cultured bovine aortic endothelial cells. Eur J Pharmacol. 2000 Aug 18;402(1-2):11-8. PubMed PMID: 10940352. 19: Samadfam R, Teixeira C, Bkaily G, Sirois P, de Brum-Fernandes A, D'Orleans-Juste P. Contribution of B(2) receptors for bradykinin in arthus reaction-induced plasma extravasation in wild-type or B(2) transgenic knockout mice. Br J Pharmacol. 2000 Apr;129(8):1732-8. PubMed PMID: 10780980; PubMed Central PMCID: PMC1571995. 20: Bastian S, Pruneau D, Loillier B, Robert C, Bonnafous JC, Paquet JL. Identification of a key region of kinin B(1) receptor for high affinity binding of peptide antagonists. J Biol Chem. 2000 Mar 3;275(9):6107-13. PubMed PMID: 10692400.